Kraj: Nowa Zelandia
Język: angielski
Źródło: Medsafe (Medicines Safety Authority)
Codeine phosphate hemihydrate 8mg; ; Paracetamol 500mg (fine); ;
GlaxoSmithKline NZ Limited
Codeine phosphate hemihydrate 8 mg
500mg/8mg
Tablet
Active: Codeine phosphate hemihydrate 8mg Paracetamol 500mg (fine) Excipient: Carnauba wax Hypromellose Maize starch Methylcellulose Opadry blue 03B50817 Potassium sorbate Povidone Purified talc Starch Stearic acid Titanium dioxide Triacetin Water
Blister pack, 1 x 12 (not marketed), 12 tablets
Pharmacy only
Pharmacy only
Tasmanian Alkaloids Pty Ltd
Package - Contents - Shelf Life: Blister pack, - 12 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, - 16 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, - 24 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, - 48 tablets - 36 months from date of manufacture stored at or below 30°C
1995-01-19
Page 1 of 9 NEW ZEALAND DATA SHEET 1. NAME OF MEDICINE Panadeine ® Tablets / Caplets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Paracetamol 500mg, Codeine Phosphate 8mg 3. PHARMACEUTICAL FORM ACTIVE INGREDIENTS CHEMICAL STRUCTURE CAS REGISTRY NUMBER Paracetamol 103-90-2 Codeine Phosphate 41444-62-6 TABLETS: Flat, round white 1.27cm tablet with bevelled edges. Front face marking “PANADEINE” with a break bar on the back face CAPLETS: white, uncoated capsule-shaped tablets, marked Panadeine with break-bar on the back face 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the temporary relief of pain and discomfort associated with • Headache • Arthritis • Migraine headache • Toothache • Tension headache • Neuralgia • Period pain • Cold & flu symptoms • Back pain • Dental procedures • Muscle pain • Sore throat Reduces fever. Page 2 of 9 4.2 DOSAGE AND ADMINISTRATION 18 YEARS - ADULTS: 2 tablets/caplets – to be taken with water four to six hours if necessary. Maximum 8 tablets/caplets in 24 hours. Do not use in children aged below 18 years. Do not exceed the stated dose or take for more than three days without a doctors advice. If symptoms persist or worsen medical advice must be sought. Should not be used with other paracetamol or codeine-containing products. Must not be used in children under 18 years. 4.3 CONTRAINDICATIONS • Previous history of hypersensitivity to paracetamol, codeine, opioid analgesics, or excipients. • Active alcoholism • Acute respiratory depression • In mothers who are breastfeeding. • Under the age of 18 years. • Those who are known to be CYP2D6 ultra-rapid metabolisers. If the patient is an extensive or ultra-rapid CYP2D6 metaboliser there is an increased risk of developing symptoms of opioid toxicity, even at commonly prescribed doses. General symptoms of opioid toxicity include confusion, somnolence, shallow breathing, small pupils, nausea, vomiting, constipation and lack of appetite. In severe cases this may include symptoms of circulatory a Przeczytaj cały dokument